About
Dr. Víctor R. De Jesús is the Acting Director of the Division of Laboratory Systems (DLS) in the Office of Laboratory Systems and Response (OLSR) at the Centers for Disease Control and Prevention (CDC).
Experience
Dr. Víctor R. De Jesús is responsible for providing leadership in managing, coordinating, and conducting DLS activities related to the development, dissemination, and promotion of regulatory and voluntary quality and safety standards and guidelines, training and workforce development, and laboratory response activities for the nation's clinical and public health laboratories. He is the lead CDC official for the federal tri-agency Clinical Laboratory Improvement Amendments of 1988 (CLIA) program. He represents DLS on the Federal Interagency Working Group on Improving Diagnostic Safety and Quality in Healthcare.
Dr. De Jesús previously served as the Chief of the Volatile Organic Compounds Laboratory, Tobacco and Volatiles Branch, National Center for Environmental Health (NCEH), where he led the CDC's efforts to characterize human exposure to harmful volatile organic compounds. He also served as the Chief of the Biochemical Mass Spectrometry Laboratory, Newborn Screening and Molecular Biology Branch, NCEH, where he led the CDC's efforts to develop mass spectrometry-based assays to characterize biomarkers of inherited metabolic disorders in dried blood spots. During his tenure in the CDC's Newborn Screening Quality Assurance Program, he launched the first global quality assurance program for lysosomal storage disorder newborn screening assays.
Dr. De Jesús has served on several committees of professional national and international organizations, including the CDC's International Symposium on Biosafety, the Clinical and Laboratory Standards Institute Consensus Council, and the Latin American Society for Neonatal Screening and Inborn Errors of Metabolism.